Tianjin
China
Tianjin Medical University - National Clinical Research Center for Cancer
single-cell, batch-correction, data integration.
lung adenocarcinoma; immune subtyping; immunotherapy; prognosis
Melanoma, Immunotherapy, NLRP3 mutations, predictive indicator
MUC16; tumor mutation load; immune microenvironment; survival outcome; immunotherapeutic efficacy; melanoma
HGSOC; Tissue specific DNA methylation; Integrative analysis; Regulation of RNA expression; TP53 mutation
homologous recombination, DNA double-strand break (DSB), genome stability, TOPBP1 loading, RPA-RAD51 exchange, PARPi, breast cancer
Agentic AI, large language models, retrieval-augmented generation, Computational Pathology, Diagnostic Decision Support, Oncologic Pathology